The nature of type 2 diabetes: The role for new agents

International Journal of Clinical Practice, Supplement

Volumn , Issue 104, 1999, Pages 14-17

  Taylor, Roy ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE; ANTIDIABETIC AGENT;

CONFERENCE PAPER; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RELEASE; INSULIN TREATMENT; INTRAVENOUS GLUCOSE TOLERANCE TEST; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; FORECASTING; REVIEW;

DIABETES MELLITUS, TYPE 2; FORECASTING; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN;

EID: 33749213404     PISSN: 1368504X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (11)

1. Taylor R, Price TB, Katz LD et al. Direct measurement of change in muscle glycogen concentration after a mixed meal in normal subjects. Am J Physiol 1993; 265: E224-E22 9.
2. Ferrannini E, Bjorkman O, Reichard GA et al. The disposal of an oral glucose load in healthy subjects' a quantitative study. Diabetes 1985; 34: 580-588.
3. McMahon M, Marsh H, Rizza RA. Comparison of the pattern of postprandial carbohydrate metabolism after ingestion of a glucose drink or a mixed meal. J Clin Endocrinol Metab 1989; 68: 647-653.
4. Taylor R, Magnusson I, Rothman DL et al. Direct assessment of liver glycogen storage by 13C nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects J Clin Invest 1996; 97: 126-132.
5. Hadden DR, Blair ALT, Wilson EA et al. Natural history of diabetes presenting age 40-69 years: a prospective study of the influence of intensive dietary therapy. Q J Med 1986; 230: 579-598.
6. Rudenski AS, Hadden DR, Atkinson AB et al. Natural history of pancreatic islet B-cell function in type 2 diabetes mellitus studied over six years by homeostasis model assessment. Diabetic Med 1988; 5: 36-41.
7. Taylor R. Insulin resistance and diabetes. Treating Diabetes 1992; 38: 2-4.
8. UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
9. Johnson AB, Argyraki M, Thow JC et al. The effect of sulphonylurea therapy on skeletal muscle glycogen synthase activity and insulin secretion in newly presenting non-insulin dependent diabetic patients. Diabetic Med 1991; 8: 243-253.
10. Taylor R, Foster B, Kyne-Grzebalski D. Insulin for the non-insulin dependent, impact on metabolic state and quality of life. Diabetic Med 1993; 10: S6 (abstract).
11. Taylor R. Resistance to injection. Diabetic Med 1992; 9: 104-108.